CLINICAL_TRIALS
trial_result
· 2012-04-19
Clinical Trial Update: Bortezomib in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Summary
Phase 2 clinical trial evaluating bortezomib in metastatic kidney cancer has completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-04-19